ANKRD2 Knockdown as a Therapeutic Strategy in Osteosarcoma: Effects on Proliferation and Drug Response in U2OS and HOS Cells

Vittoria Cenni(Istituto Ortopedico Rizzoli), William L. Blalock(Istituto Ortopedico Rizzoli)

International Journal of Molecular Sciences

February 18, 2025

10.3390/ijms26041736

Cited by 1

Related Papers

Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H<sub>2</sub>O<sub>2</sub>

|Molecular Biology of the Cell|2011|51

Rapamycin treatment of Mandibuloacral Dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics

|Aging|2014|34

Desmin and Plectin Recruitment to the Nucleus and Nuclei Orientation Are Lost in Emery-Dreifuss Muscular Dystrophy Myoblasts Subjected to Mechanical Stimulation

|Cells|2024|6